Contact Us (781) 301-7474

 

About Hemanext

Learn more about Hemanext to envision a world with fewer, better transfusions.

Who We Are

Hemanext is a medical technology company with corporate headquarters in Lexington, MA and manufacturing operations in Avon, MA. Our corporate mission is to support the transfusion medicine community in its efforts to save lives and improve patient outcomes. Our distinctive focus is on innovations that promote dramatic improvements in transfusion therapy.

Our current focus is on:

Hemanext ONE®

An innovative storage system for red blood cells. This technology has been developed with funding from private investors as well as grants and development contracts from the National Institutes of Health.

The Hemanext ONE® System has not been cleared or approved by FDA or any regulatory agency for commercial distribution. The product is pending CE mark certification.

Our Science

Learn about the journey of red blood cells after donation including degradation that occurs during storage and discover the potential of hypoxic storage to alleviate this problem.

Stored Blood

The average human body stores about 5.6 liters of blood. As it circulates through the body several times each minute, it accomplishes a variety of functions.

Storage Lesion

The existence of the storage lesion process has been well established, and recent scientific work has increased the precision and depth.

Clinical Implications

Numerous studies pertaining to clinical implications of storage lesion suggest a linkage to hyper-coagulability, inflammation, impaired perfusion, immuno-modulation, organ dysfunction13, and mortality14.

Hypoxic Storage

Hemanext is developing a technology to enable the storage of RBC under hypoxic conditions. Removing O2 during storage removes the primary “fuel” for oxidative stress1-11.

CONNECT WITH HEMANEXT TODAY TO LEARN MORE!

We are happy to answer any questions about the company, our technology, or our research. Fill out the form below and we will connect with you!